vs
BIOCRYST PHARMACEUTICALS INC（BCRX）与Pattern Group Inc.（PTRN）财务数据对比。点击上方公司名可切换其他公司
Pattern Group Inc.的季度营收约是BIOCRYST PHARMACEUTICALS INC的1.6倍（$639.7M vs $406.6M），BIOCRYST PHARMACEUTICALS INC净利率更高（60.5% vs -9.2%，领先69.7%），BIOCRYST PHARMACEUTICALS INC自由现金流更多（$291.2M vs $75.7M）
BioCryst Pharmaceuticals是一家总部位于美国北卡罗来纳州达勒姆的制药企业，属于后期发展阶段的生物科技公司，聚焦于治疗罕见重症的口服药物研发。其研发的抗病毒药物帕拉米韦（商品名Rapivab）于2014年12月获得美国FDA批准，此后也陆续在日本、韩国与中国获批上市。
Pattern Energy Group是一家美国可再生能源企业，专注于开发、持有及运营公用事业级风电和光伏设施，业务覆盖美国、加拿大及墨西哥市场，总部位于加利福尼亚州旧金山，在得克萨斯州休斯敦设有运营中心。
BCRX vs PTRN — 直观对比
营收规模更大
PTRN
是对方的1.6倍
$406.6M
净利率更高
BCRX
高出69.7%
-9.2%
自由现金流更多
BCRX
多$215.4M
$75.7M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $406.6M | $639.7M |
| 净利润 | $245.8M | $-59.1M |
| 毛利率 | 97.7% | 44.3% |
| 营业利润率 | 64.0% | -9.4% |
| 净利率 | 60.5% | -9.2% |
| 营收同比 | 209.1% | — |
| 净利润同比 | 1017.5% | — |
| 每股收益（稀释后） | $1.13 | $-2.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCRXPTRN
| Q4 25 | $406.6M | — | ||
| Q3 25 | $159.4M | $639.7M | ||
| Q2 25 | $163.4M | — | ||
| Q1 25 | $145.5M | — | ||
| Q4 24 | $131.5M | — | ||
| Q3 24 | $117.1M | — | ||
| Q2 24 | $109.3M | — | ||
| Q1 24 | $92.8M | — |
净利润BCRXPTRN
| Q4 25 | $245.8M | — | ||
| Q3 25 | $12.9M | $-59.1M | ||
| Q2 25 | $5.1M | — | ||
| Q1 25 | $32.0K | — | ||
| Q4 24 | $-26.8M | — | ||
| Q3 24 | $-14.0M | — | ||
| Q2 24 | $-12.7M | — | ||
| Q1 24 | $-35.4M | — |
毛利率BCRXPTRN
| Q4 25 | 97.7% | — | ||
| Q3 25 | 98.6% | 44.3% | ||
| Q2 25 | 98.3% | — | ||
| Q1 25 | 96.9% | — | ||
| Q4 24 | 95.4% | — | ||
| Q3 24 | 97.3% | — | ||
| Q2 24 | 98.4% | — | ||
| Q1 24 | 98.6% | — |
营业利润率BCRXPTRN
| Q4 25 | 64.0% | — | ||
| Q3 25 | 18.6% | -9.4% | ||
| Q2 25 | 18.2% | — | ||
| Q1 25 | 14.6% | — | ||
| Q4 24 | -3.4% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 8.0% | — | ||
| Q1 24 | -15.6% | — |
净利率BCRXPTRN
| Q4 25 | 60.5% | — | ||
| Q3 25 | 8.1% | -9.2% | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | -20.4% | — | ||
| Q3 24 | -12.0% | — | ||
| Q2 24 | -11.6% | — | ||
| Q1 24 | -38.1% | — |
每股收益（稀释后）BCRXPTRN
| Q4 25 | $1.13 | — | ||
| Q3 25 | $0.06 | $-2.19 | ||
| Q2 25 | $0.02 | — | ||
| Q1 25 | $0.00 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $-0.07 | — | ||
| Q2 24 | $-0.06 | — | ||
| Q1 24 | $-0.17 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $274.7M | $312.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-119.2M | $541.4M |
| 总资产 | $514.2M | $843.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCRXPTRN
| Q4 25 | $274.7M | — | ||
| Q3 25 | $212.9M | $312.8M | ||
| Q2 25 | $260.0M | — | ||
| Q1 25 | $295.1M | — | ||
| Q4 24 | $320.9M | — | ||
| Q3 24 | $96.8M | — | ||
| Q2 24 | $78.4M | — | ||
| Q1 24 | $84.3M | — |
股东权益BCRXPTRN
| Q4 25 | $-119.2M | — | ||
| Q3 25 | $-387.9M | $541.4M | ||
| Q2 25 | $-421.6M | — | ||
| Q1 25 | $-451.9M | — | ||
| Q4 24 | $-475.9M | — | ||
| Q3 24 | $-468.6M | — | ||
| Q2 24 | $-475.6M | — | ||
| Q1 24 | $-476.2M | — |
总资产BCRXPTRN
| Q4 25 | $514.2M | — | ||
| Q3 25 | $446.4M | $843.1M | ||
| Q2 25 | $457.2M | — | ||
| Q1 25 | $480.0M | — | ||
| Q4 24 | $490.4M | — | ||
| Q3 24 | $491.3M | — | ||
| Q2 24 | $472.4M | — | ||
| Q1 24 | $467.9M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $292.0M | $90.9M |
| 自由现金流经营现金流 - 资本支出 | $291.2M | $75.7M |
| 自由现金流率自由现金流/营收 | 71.6% | 11.8% |
| 资本支出强度资本支出/营收 | 0.2% | 2.4% |
| 现金转化率经营现金流/净利润 | 1.19× | — |
| 过去12个月自由现金流最近4个季度 | $344.9M | — |
8季度趋势，按日历期对齐
经营现金流BCRXPTRN
| Q4 25 | $292.0M | — | ||
| Q3 25 | $41.6M | $90.9M | ||
| Q2 25 | $41.3M | — | ||
| Q1 25 | $-27.5M | — | ||
| Q4 24 | $-5.2M | — | ||
| Q3 24 | $8.2M | — | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $-53.7M | — |
自由现金流BCRXPTRN
| Q4 25 | $291.2M | — | ||
| Q3 25 | $40.3M | $75.7M | ||
| Q2 25 | $41.1M | — | ||
| Q1 25 | $-27.7M | — | ||
| Q4 24 | $-5.9M | — | ||
| Q3 24 | $8.2M | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-53.9M | — |
自由现金流率BCRXPTRN
| Q4 25 | 71.6% | — | ||
| Q3 25 | 25.3% | 11.8% | ||
| Q2 25 | 25.2% | — | ||
| Q1 25 | -19.0% | — | ||
| Q4 24 | -4.5% | — | ||
| Q3 24 | 7.0% | — | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | -58.1% | — |
资本支出强度BCRXPTRN
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.8% | 2.4% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.3% | — |
现金转化率BCRXPTRN
| Q4 25 | 1.19× | — | ||
| Q3 25 | 3.23× | — | ||
| Q2 25 | 8.12× | — | ||
| Q1 25 | -859.91× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCRX
暂无分部数据
PTRN
| Amazon.com | $549.2M | 86% |
| Amazon Marketplaces International | $43.4M | 7% |
| Other Online Marketplaces And Channels | $39.4M | 6% |
| Saa S Logistics And Other Revenue | $7.7M | 1% |
